GET THE APP

Virology & Mycology

Virology & Mycology
Open Access

ISSN: 2161-0517

Alan Epstein L

Alan Epstein L

Alan Epstein L
Professor, Pathology,Health Sciences Campus
University of Southern California, Keck School Faculty, USA

Biography

Alan L. Epstein MD, PhD is a Professor at the Keck School of Medicine at the University of Southern California and has over 30 years of experience in the laboratory developing monoclonal antibodies and other reagents for the treatment of cancer. He has published over 150 papers in the field and has filed 25 patents including those describing the use of TNT antibodies for the imaging and therapy of cancer. Along with TNT antibodies, Dr. Epstein has invented the Lym-1 antibody for the treatment of lymphoma, vasopermeability enhancing antibodies to increase the uptake of drugs and antibodies in tumors, the LN panel of diagnostic antibodies, and most recently several novel fusion proteins for the immunotherapy of cancer. He has been a consultant for numerous biotechnology companies and is an accomplished speaker and scientist in his field. Dr. Epstein holds a bachelor’s degree in biology from Wesleyan University, Middletown, CT and obtained the MD and PhD degrees from the Medical Scientist Training Program at Stanford University School of Medicine. Before coming to the University of Southern California, Dr. Epstein started his academic career in the Department of Medicine, Division of Medical Oncology at the Northwestern University School of Medicine in Chicago.

Research Interest

Cell culture and biology of cancer; immunodiagnosis of tumors; immunotherapy of cancer using monoclonal antibodies, fusion proteins, and Fc soluble proteins; identification and reversal of immunosuppressive mechanisms associated with immune evasion by tumors.

Top